{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:20:11Z","timestamp":1791577211157,"version":"4.3.4"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2016-02364582"],"award-info":[{"award-number":["RF-2016-02364582"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jad.2022.04.050","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T11:05:38Z","timestamp":1649847938000},"page":"314-321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Effects of pharmacological treatments on neuroimaging findings in borderline personality disorder: A review of FDG-PET and fNIRS studies"],"prefix":"10.1016","volume":"308","author":[{"given":"Giulia","family":"Cattarinussi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Delvecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Moltrasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Sambataro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Brambilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2022.04.050_bb0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jad.2008.01.024","article-title":"Evidenced-based pharmacologic treatment of borderline personality disorder: a shift from SSRIs to anticonvulsants and atypical antipsychotics?","volume":"111","author":"Abraham","year":"2008","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.04.050_bb0010","doi-asserted-by":"crossref","DOI":"10.3174\/ajnr.A1175","article-title":"Brain single-photon emission CT physics principles","author":"Accorsi","year":"2008","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.jad.2022.04.050_bb0015","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/ijnp\/pyz003","article-title":"Venlafaxine ER blocks the norepinephrine transporter in the brain of patients with major depressive disorder: a PET study using [18F]FMeNER-D2","volume":"22","author":"Arakawa","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2022.04.050_bb0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1749-6632.1986.tb27903.x","article-title":"An overview","volume":"487","author":"\u00c5sberg","year":"1986","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jad.2022.04.050_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(14)61394-5","article-title":"Treatment of personality disorder","author":"Bateman","year":"2015","journal-title":"Lancet."},{"key":"10.1016\/j.jad.2022.04.050_bb0030","series-title":"NeuroImage","first-page":"S275","article-title":"Diffuse optical imaging of brain activation: approaches to optimizing image sensitivity, resolution, and accuracy","author":"Boas","year":"2004"},{"key":"10.1016\/j.jad.2022.04.050_bb0035","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/acps.12997","article-title":"Patterns of altered regional brain glucose metabolism in borderline personality disorder and bipolar II disorder","volume":"139","author":"B\u00f8en","year":"2019","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2022.04.050_bb0040","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0925-4927(99)00034-7","article-title":"Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine","volume":"91","author":"Brody","year":"1999","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2022.04.050_bb0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0006-3223(96)00097-2","article-title":"Effect of sertraline on regional metabolic rate in patients with affective disorder","volume":"41","author":"Buchsbaum","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2022.04.050_bb0050","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.schres.2007.04.027","article-title":"FDG-PET in never-previously medicated psychotic adolescents treated with olanzapine or haloperidol","volume":"94","author":"Buchsbaum","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2022.04.050_bb0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.schres.2009.07.015","article-title":"FDG-PET and MRI imaging of the effects of sertindole and haloperidol in the prefrontal lobe in schizophrenia","volume":"114","author":"Buchsbaum","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2022.04.050_bb0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pscychresns.2018.06.015","article-title":"Brain metabolism changes in women with BPD undergoing olanzapine treatment","volume":"279","author":"Camchong","year":"2018","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.jad.2022.04.050_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2021.03.088","article-title":"Effects of pharmacological treatments on emotional tasks in borderline personality disorder: a review of functional magnetic resonance imaging studies","author":"Cattarinussi","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.04.050_bb0070","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1176\/ps.2007.58.3.335","article-title":"Demographic and clinical profiles of patients who make multiple visits to psychiatric emergency services","volume":"58","author":"Chaput","year":"2007","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.jad.2022.04.050_bb0075","article-title":"Functional near-infrared spectroscopy and its clinical application in the field of neuroscience: advances and future directions","author":"Chen","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jad.2022.04.050_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2020.07.117","article-title":"Borderline personality disorder, metacognition and psychotherapy","author":"D\u2019Abate","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.04.050_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroscience.2012.03.065","article-title":"Dopamine, serotonin and impulsivity","author":"Dalley","year":"2012","journal-title":"Neuroscience."},{"key":"10.1016\/j.jad.2022.04.050_bb0090","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jad.2006.10.028","article-title":"Effects of antidepressant treatment on neural correlates of emotional and neutral declarative verbal memory in depression","volume":"101","author":"Douglas Bremner","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.04.050_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-020-01088-7","article-title":"Intrinsic organization of cortical networks predicts state anxiety: an functional near-infrared spectroscopy (fNIRS) study","volume":"10","author":"Duan","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2022.04.050_bb0100","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jad.2020.12.048","article-title":"Differentiating between bipolar and unipolar depression using prefrontal activation patterns: promising results from functional near infrared spectroscopy (fNIRS) findings","volume":"281","author":"Feng","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.04.050_bb0105","first-page":"537","article-title":"The promise of near-infrared spectroscpy (NIRS) for psychological research: a brief review","volume":"3","author":"Ferreri","year":"2014","journal-title":"Cogn. Psychol."},{"key":"10.1016\/j.jad.2022.04.050_bb0110","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2015.4557","article-title":"Reducing suicide risk in borderline personality disorder","author":"Gunderson","year":"2015","journal-title":"JAMA - J. Am. Med. Assoc."},{"key":"10.1016\/j.jad.2022.04.050_bb0115","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.psychres.2018.12.030","article-title":"F-18Fluorodeoxyglucose positron emission tomography studies of the schizophrenia spectrum: the legacy of Monte S. Buchsbaum, M.D","volume":"271","author":"Hazlett","year":"2019","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2022.04.050_bb0125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1176\/ajp.153.1.41","article-title":"Functional sites of neuroleptic drug action in the human brain: PET\/FDG studies with and without haloperidol","volume":"153","author":"Holcomb","year":"1996","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2022.04.050_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.11.047","article-title":"Cortical haemodynamic response measured by functional near infrared spectroscopy during a verbal fluency task in patients with major depression and borderline personality disorder","volume":"51","author":"Husain","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jad.2022.04.050_bb0135","series-title":"Cortical Haemodynamic Response During the Verbal Fluency Task in Patients With Bipolar Disorder and Borderline Personality Disorder: A Preliminary Functional Near-Infrared Spectroscopy Study","author":"Husain","year":"2021"},{"key":"10.1016\/j.jad.2022.04.050_bb0140","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1600-0447.2008.01231.x","article-title":"Cumulative prevalence of personality disorders between adolescence and adulthood","volume":"118","author":"Johnson","year":"2008","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2022.04.050_bb0145","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0022-3956(02)00084-5","article-title":"Positron emission tomography in female patients with borderline personality disorder","volume":"37","author":"Juengling","year":"2003","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2022.04.050_bb0150","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000337740","article-title":"Regional brain metabolism and treatment response in panic disorder patients: an [F]FDG-PET study","volume":"66","author":"Kang","year":"2012","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jad.2022.04.050_bb0155","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1176\/appi.ajp.158.6.899","article-title":"Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression","volume":"158","author":"Kennedy","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2022.04.050_bb0160","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1521\/suli.2010.40.6.612","article-title":"Rethinking impulsivity in suicide","volume":"40","author":"Klonsky","year":"2010","journal-title":"Suicide Life Threat. Behav."},{"key":"10.1016\/j.jad.2022.04.050_bb0165","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00213-012-2885-8","article-title":"Effects of sedative antidepressants on prefrontal cortex activity during verbal fluency task in healthy subjects: a near-infrared spectroscopy study","volume":"226","author":"Kohmura","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2022.04.050_bb0170","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.neuroimage.2013.11.001","article-title":"Neural network of cognitive emotion regulation - an ALE meta-analysis and MACM analysis","volume":"87","author":"Kohn","year":"2014","journal-title":"Neuroimage"},{"key":"10.1016\/j.jad.2022.04.050_bb0175","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.schres.2011.07.014","article-title":"Different hemodynamic response patterns in the prefrontal cortical sub-regions according to the clinical stages of psychosis","volume":"132","author":"Koike","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2022.04.050_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2013.00145","article-title":"Near-infrared spectroscopy in schizophrenia: a possible biomarker for predicting clinical outcome and treatment response","volume":"4","author":"Koike","year":"2013","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jad.2022.04.050_bb0185","doi-asserted-by":"crossref","DOI":"10.1007\/s11920-019-1011-6","article-title":"Single-photon emission computed tomography and positron emission tomography studies of antisocial personality disorder and aggression: a targeted review","author":"Kolla","year":"2019","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.jad.2022.04.050_bb0190","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.comppsych.2008.01.007","article-title":"Estimating the prevalence of borderline personality disorder in psychiatric outpatients using a two-phase procedure","volume":"49","author":"Korzekwa","year":"2008","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jad.2022.04.050_bb0195","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jad.2019.07.021","article-title":"Altered biochemical metabolism and its lateralization in the cortico-striato-cerebellar circuit of unmedicated bipolar II depression","volume":"259","author":"Lai","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.04.050_bb0200","series-title":"Lancet","first-page":"453","article-title":"Borderline personality disorder","author":"Lieb","year":"2004"},{"key":"10.1016\/j.jad.2022.04.050_bb0205","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1001\/jamapsychiatry.2014.3039","article-title":"Dialectical behavior therapy for high suicide risk in individuals with borderline personality disorder: a randomized clinical trial and component analysis","volume":"72","author":"Linehan","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2022.04.050_bb0210","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.biopsych.2004.10.033","article-title":"Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression","volume":"57","author":"Little","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2022.04.050_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/S0893-133X(00)00228-1","article-title":"The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system","author":"Mann","year":"2001","journal-title":"Neuropsychopharmacology."},{"key":"10.1016\/j.jad.2022.04.050_bb0220","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/bdi.12710","article-title":"The metabolic basis of psychosis in bipolar disorder: a positron emission tomography study","volume":"21","author":"Marotta","year":"2019","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2022.04.050_bb0225","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.neuroimage.2013.04.098","article-title":"Prefrontal activation in response to emotional words in patients with bipolar disorder and major depressive disorder","volume":"85","author":"Matsubara","year":"2014","journal-title":"Neuroimage"},{"key":"10.1016\/j.jad.2022.04.050_bb0230","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pscychresns.2013.02.002","article-title":"Childhood abuse is associated with structural impairment in the ventrolateral prefrontal cortex and aggressiveness in patients with borderline personality disorder","volume":"213","author":"Morandotti","year":"2013","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.jad.2022.04.050_bb0235","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00213-004-1913-8","article-title":"Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression","volume":"176","author":"New","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2022.04.050_bb0240","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jpsychires.2006.03.010","article-title":"Association between serotonin transporter gene and borderline personality disorder","volume":"40","author":"Ni","year":"2006","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2022.04.050_bb0245","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000437431","article-title":"Social function and Frontopolar activation during a cognitive task in patients with bipolar disorder","volume":"72","author":"Nishimura","year":"2015","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jad.2022.04.050_bb0250","author":"Oldham","year":"2010"},{"key":"10.1016\/j.jad.2022.04.050_bb0255","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1161\/01.RES.44.1.127","article-title":"The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man","volume":"44","author":"Reivich","year":"1979","journal-title":"Circ. Res."},{"key":"10.1016\/j.jad.2022.04.050_bb0260","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pscychresns.2010.01.011","article-title":"Abnormal prefrontal cortical response during affective processing in borderline personality disorder","volume":"182","author":"Ruocco","year":"2010","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.jad.2022.04.050_bb0265","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.pscychresns.2009.12.001","article-title":"Medial prefrontal cortex hyperactivation during social exclusion in borderline personality disorder","volume":"181","author":"Ruocco","year":"2010","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.jad.2022.04.050_bb0270","article-title":"Neurophysiological biomarkers of response inhibition and the familial risk for borderline personality disorder","volume":"110115","author":"Ruocco","year":"2020","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2022.04.050_bb0275","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pscychresns.2006.06.001","article-title":"Regional brain serotonin and dopamine transporter binding capacity in suicide attempters relate to impulsiveness and mental energy","volume":"148","author":"Ryding","year":"2006","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.jad.2022.04.050_bb0280","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jad.2010.11.036","article-title":"Dorsolateral prefrontal cortex and hippocampus sustain impulsivity and aggressiveness in borderline personality disorder","volume":"131","author":"Sala","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.04.050_bb0285","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jad.2011.01.001","article-title":"Fronto-limbic dysfunction in borderline personality disorder: a 18F-FDG positron emission tomography study","volume":"131","author":"Salavert","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.04.050_bb0290","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jad.2020.12.094","article-title":"Cortical activity measured by functional near infrared spectroscopy during a theory of mind task in subjects with schizophrenia, bipolar disorder and healthy controls","volume":"282","author":"Sayar-Akaslan","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.04.050_bb0295","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pscychresns.2013.05.007","article-title":"An exploratory study of the relationship of symptom domains and diagnostic severity to PET scan imaging in borderline personality disorder","volume":"214","author":"Schulz","year":"2013","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2022.04.050_bb0300","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jad.2020.12.153","article-title":"fNIRS study of prefrontal activation during emotion recognition\u2013a potential endophenotype for bipolar I disorder?","volume":"282","author":"Segar","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.04.050_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.psc.2018.07.009","article-title":"Comorbidity of borderline personality disorder: current status and future directions","author":"Shah","year":"2018","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.jad.2022.04.050_bb0310","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.biopsych.2007.11.016","article-title":"Decreased [18F]MPPF binding potential in the dorsal raphe nucleus after a single oral dose of fluoxetine: a positron-emission tomography study in healthy volunteers","volume":"63","author":"Sibon","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2022.04.050_bb0315","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0006-3223(99)00202-4","article-title":"A fenfluramine-activated FDG-PET study of borderline personality disorder","volume":"47","author":"Soloff","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2022.04.050_bb0320","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0925-4927(03)00064-7","article-title":"Impulsivity and prefrontal hypometabolism in borderline personality disorder","volume":"123","author":"Soloff","year":"2003","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.jad.2022.04.050_bb0325","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pscychresns.2005.02.008","article-title":"Gender differences in a fenfluramine-activated FDG PET study of borderline personality disorder","volume":"138","author":"Soloff","year":"2005","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.jad.2022.04.050_bb0330","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jpsychires.2021.04.035","article-title":"Neural correlates of citalopram and placebo response in acute bipolar depression: a randomized trial","volume":"138","author":"Sretavan Wong","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2022.04.050_bb0335","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/bmj.b2880","article-title":"Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration","volume":"339","author":"Stone","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2022.04.050_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.pedhc.2010.09.006","article-title":"The PRISMA statement: a guideline for systematic reviews and meta-analyses","author":"Swartz","year":"2011","journal-title":"J. Pediatr. Heal. Care."},{"key":"10.1016\/j.jad.2022.04.050_bb0345","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.schres.2007.10.025","article-title":"Reduced frontopolar activation during verbal fluency task in schizophrenia: a multi-channel near-infrared spectroscopy study","volume":"99","author":"Takizawa","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2022.04.050_bb0350","doi-asserted-by":"crossref","DOI":"10.1097\/JCP.0000000000000065","article-title":"Dose and dosing frequency of long-acting injectable antipsychotics a systematic review of PET and SPECT data and clinical implications","author":"Uchida","year":"2014","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2022.04.050_bb0355","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jad.2016.07.025","article-title":"Mapping the brain correlates of borderline personality disorder: a functional neuroimaging meta-analysis of resting state studies","volume":"204","author":"Visintin","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.04.050_bb0360","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00213-007-0806-z","article-title":"Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography","volume":"193","author":"Voineskos","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2022.04.050_bb0365","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/scan\/nsab017","article-title":"A systematic review of studies that used NIRS to measure neural activation during emotion processing in healthy individuals","volume":"16","author":"Westgarth","year":"2021","journal-title":"Soc. Cogn. Affect. Neurosci."},{"key":"10.1016\/j.jad.2022.04.050_bb0370","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00406-012-0303-1","article-title":"Orbitofrontal cortex and impulsivity in borderline personality disorder: an MRI study of baseline brain perfusion","volume":"262","author":"Wolf","year":"2012","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2022.04.050_bb0375","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1600-0447.2004.00362.x","article-title":"Axis II comorbidity of borderline personality disorder: description of 6-year course and prediction to time-to-remission","volume":"110","author":"Zanarini","year":"2004","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2022.04.050_bb0380","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jad.2014.07.024","article-title":"Similarities of biochemical abnormalities between major depressive disorder and bipolar depression: a proton magnetic resonance spectroscopy study","volume":"168","author":"Zhong","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.04.050_bb0385","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neulet.2010.05.003","article-title":"Reduced prefrontal activation during tower of London in first-episode schizophrenia: a multi-channel near-infrared spectroscopy study","volume":"478","author":"Zhu","year":"2010","journal-title":"Neurosci. Lett."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032722003883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032722003883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T03:17:21Z","timestamp":1759029441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032722003883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":76,"alternative-id":["S0165032722003883"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2022.04.050","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of pharmacological treatments on neuroimaging findings in borderline personality disorder: A review of FDG-PET and fNIRS studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2022.04.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}